Jeffrey A Linder1, Harry Reyes Nieva, William A Blumentals. 1. Division of General Medicine and Primary Care, Brigham and Women's Hospital, 1620 Tremont Street, BC-3-2X, Boston, MA 02120, USA. jlinder@partners.org
Abstract
BACKGROUND: Anti-influenza antiviral medications reduce influenza-related morbidity, but may often be used inappropriately. OBJECTIVE: To measure the rate of antiviral and antibiotic prescribing, the appropriateness of antiviral prescribing, and evaluate independent predictors of antiviral and antibiotic prescribing for influenza in primary care. DESIGN AND PATIENTS: Retrospective analysis of 958 visits of clinician-diagnosed influenza in 21 primary care clinics in eastern Massachusetts from 1999 to 2007. We considered antiviral prescribing appropriate if patients had symptoms for 2 or fewer days, had fever, and any 2 of headache, sore throat, cough, or myalgias. MEASUREMENTS AND MAIN RESULTS: Clinicians prescribed antivirals in 557 (58%) visits and antibiotics in 104 visits (11%). Of antiviral prescriptions, 38% were not appropriate, most commonly because of symptoms for more than 2 days (24% of antiviral prescriptions). In multivariate modeling, selected independent predictors of antiviral prescribing were symptom duration of 2 or fewer days (odds ratio [OR], 12.4; 95% confidence interval [CI], 8.3 to 18.6), year (OR, 1.4 for each successive influenza season; 95% CI, 1.3 to 1.7), patient age (OR, 1.3 per decade; 95% CI, 1.2 to 1.5), and, compared to having no influenza testing, having a negative influenza test (OR, 5.5; 95% CI, 3.4 to 9.1) or a positive influenza test (OR, 11.4; 95% CI, 6.7 to 19.3). Independent predictors of antibiotic prescribing included otoscopic abnormalities (OR, 3.3; 95% CI, 1.8 to 6.0), abnormal lung examination (OR, 4.0; 95% CI, 2.1 to 6.2), and having a chest x-ray performed (OR, 2.2; 95% CI, 1.3 to 3.8). CONCLUSIONS: Primary care clinicians are much more likely to prescribe antivirals to patients with symptoms for 2 or fewer days, but also commonly prescribe antivirals inappropriately.
BACKGROUND: Anti-influenza antiviral medications reduce influenza-related morbidity, but may often be used inappropriately. OBJECTIVE: To measure the rate of antiviral and antibiotic prescribing, the appropriateness of antiviral prescribing, and evaluate independent predictors of antiviral and antibiotic prescribing for influenza in primary care. DESIGN AND PATIENTS: Retrospective analysis of 958 visits of clinician-diagnosed influenza in 21 primary care clinics in eastern Massachusetts from 1999 to 2007. We considered antiviral prescribing appropriate if patients had symptoms for 2 or fewer days, had fever, and any 2 of headache, sore throat, cough, or myalgias. MEASUREMENTS AND MAIN RESULTS: Clinicians prescribed antivirals in 557 (58%) visits and antibiotics in 104 visits (11%). Of antiviral prescriptions, 38% were not appropriate, most commonly because of symptoms for more than 2 days (24% of antiviral prescriptions). In multivariate modeling, selected independent predictors of antiviral prescribing were symptom duration of 2 or fewer days (odds ratio [OR], 12.4; 95% confidence interval [CI], 8.3 to 18.6), year (OR, 1.4 for each successive influenza season; 95% CI, 1.3 to 1.7), patient age (OR, 1.3 per decade; 95% CI, 1.2 to 1.5), and, compared to having no influenza testing, having a negative influenza test (OR, 5.5; 95% CI, 3.4 to 9.1) or a positive influenza test (OR, 11.4; 95% CI, 6.7 to 19.3). Independent predictors of antibiotic prescribing included otoscopic abnormalities (OR, 3.3; 95% CI, 1.8 to 6.0), abnormal lung examination (OR, 4.0; 95% CI, 2.1 to 6.2), and having a chest x-ray performed (OR, 2.2; 95% CI, 1.3 to 3.8). CONCLUSIONS: Primary care clinicians are much more likely to prescribe antivirals to patients with symptoms for 2 or fewer days, but also commonly prescribe antivirals inappropriately.
Authors: Susan K Bowles; Wayne Lee; Andrew E Simor; Mary Vearncombe; Mark Loeb; Susan Tamblyn; Margaret Fearon; Yan Li; Allison McGeer Journal: J Am Geriatr Soc Date: 2002-04 Impact factor: 5.562
Authors: J Alexander Cole; Jeanne E Loughlin; Anuli N Ajene; Daniel M Rosenberg; Suzanne E Cook; Alexander M Walker Journal: Clin Ther Date: 2002-11 Impact factor: 3.393
Authors: Charlesnika T Evans; Thea J Rogers; Barry Goldstein; Frances M Weaver; Sherri L LaVela Journal: J Spinal Cord Med Date: 2014-06-24 Impact factor: 1.985
Authors: Ashley L Fowlkes; Andrea Steffens; Carrie Reed; Jonathan L Temte; Angela P Campbell Journal: Open Forum Infect Dis Date: 2019-04-26 Impact factor: 3.835
Authors: Léon Nshimyumukiza; Xavier Douville; Diane Fournier; Julie Duplantie; Rana K Daher; Isabelle Charlebois; Jean Longtin; Jesse Papenburg; Maryse Guay; Maurice Boissinot; Michel G Bergeron; Denis Boudreau; Christian Gagné; François Rousseau; Daniel Reinharz Journal: Influenza Other Respir Viruses Date: 2016-01-29 Impact factor: 4.380
Authors: Simon de Lusignan; Uy Hoang; Harshana Liyanage; Ivelina Yonova; Filipa Ferreira; Javier Diez-Domingo; Tristan Clark Journal: JMIR Res Protoc Date: 2019-11-11